6681 related articles for article (PubMed ID: 18018602)
1. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of testing methods on acid-fast bacteria].
Ichiyama S; Suzuki K
Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
7. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
8. [Exogenous re-infection in tuberculosis].
Tsuchiya T
Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
[TBL] [Abstract][Full Text] [Related]
9. [New era in molecular epidemiology of tuberculosis in Japan].
Takashima T; Iwamoto T
Kekkaku; 2006 Nov; 81(11):693-707. PubMed ID: 17154049
[TBL] [Abstract][Full Text] [Related]
10. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
Okada M; Kita Y
Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
[TBL] [Abstract][Full Text] [Related]
11. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
12. A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Nagasawa T; Kaneda Y; Yoshida S; Matsumoto M; Paul S; Tan EV; Cruz ECD; N McMurray D; Sakatani M
Procedia Vaccinol; 2010; 2(1):34-39. PubMed ID: 32288910
[TBL] [Abstract][Full Text] [Related]
13. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
15. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Fukamizu R; Tsunai Y; Inoue R; Nakatani H; Namie Y; Yamada J; Takao K; Asai R; Asaki R; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Sakatani M
Vaccine; 2007 Apr; 25(16):2990-3. PubMed ID: 17280753
[TBL] [Abstract][Full Text] [Related]
17. [Genetic research about Mycobacterium avium complex].
Ogawa K
Kekkaku; 2011 Feb; 86(2):61-8. PubMed ID: 21404652
[TBL] [Abstract][Full Text] [Related]
18. A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model.
Okada M; Kita Y; Nakajima T; Kanamaru N; Kaneda Y; Saunderson P; Tan EV; McMurray DN
Procedia Vaccinol; 2011; 4():42-49. PubMed ID: 32288912
[TBL] [Abstract][Full Text] [Related]
19. [The development of novel vaccines against tuberculosis].
Okada M
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):356-68. PubMed ID: 18974619
[TBL] [Abstract][Full Text] [Related]
20. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
Okada M; Kita Y; Hashimoto S; Nakatani H; Nishimastu S; Kioka Y; Takami Y
Hum Vaccin Immunother; 2017 Feb; 13(2):298-305. PubMed ID: 27960629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
